-
公开(公告)号:US07247751B2
公开(公告)日:2007-07-24
申请号:US11439570
申请日:2006-05-23
IPC分类号: C07C211/00
CPC分类号: C07C209/84 , C07C209/90 , C07C271/12 , C07C211/30 , C07C211/63
摘要: The invention provides processes for the preparation of cinacalcet hydrochloride crystalline Form I.
摘要翻译: 本发明提供了制备盐酸西那卡塞结晶I的方法。
-
12.Eluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 失效
标题翻译: Eluvastatin钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US20050032884A1
公开(公告)日:2005-02-10
申请号:US10872089
申请日:2004-06-18
IPC分类号: A61P3/06 , C07D209/24 , A61K31/225
CPC分类号: C07D209/12 , C07D209/24
摘要: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
摘要翻译: 提供氟伐他汀钠的多晶型物质及其制备方法。
-
13.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 失效
标题翻译: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US20080146817A1
公开(公告)日:2008-06-19
申请号:US11699659
申请日:2007-01-29
IPC分类号: C07D209/04
CPC分类号: C07D209/12 , C07D209/24
摘要: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
摘要翻译: 提供氟伐他汀钠的结晶形式及其制备方法。
-
14.Crystalline forms of ibandronic acid and processes for preparation thereof 审中-公开
标题翻译: 伊班膦酸的结晶形式及其制备方法公开(公告)号:US20080009466A1
公开(公告)日:2008-01-10
申请号:US11789984
申请日:2007-04-25
CPC分类号: C07F9/3873
摘要: The invention relates to solid crystalline forms of ibandronic acid, pharmaceutical formulations thereof, and methods of treatment therewith.
摘要翻译: 本发明涉及伊班膦酸的固体结晶形式,其药物制剂及其处理方法。
-
公开(公告)号:US20070099998A1
公开(公告)日:2007-05-03
申请号:US11439570
申请日:2006-05-23
IPC分类号: A61K31/137 , C07C211/27
CPC分类号: C07C209/84 , C07C209/90 , C07C271/12 , C07C211/30 , C07C211/63
摘要: The invention provides processes for the preparation of cinacalcet hydrochloride crystalline Form I.
摘要翻译: 本发明提供了制备盐酸西那卡塞结晶I的方法。
-
16.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 失效
标题翻译: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US07687642B2
公开(公告)日:2010-03-30
申请号:US11699659
申请日:2007-01-29
IPC分类号: C07D209/12
CPC分类号: C07D209/12 , C07D209/24
摘要: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
摘要翻译: 提供氟伐他汀钠的结晶形式及其制备方法。
-
17.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 审中-公开
标题翻译: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US20090118518A1
公开(公告)日:2009-05-07
申请号:US12150949
申请日:2008-04-30
IPC分类号: C07D209/04
CPC分类号: C07D209/12 , C07D209/24
摘要: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
摘要翻译: 提供氟伐他汀钠的结晶形式及其制备方法。
-
18.Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them 失效
标题翻译: 氟伐他汀钠晶体形式,其制备方法,含有它们的组合物和使用它们的方法公开(公告)号:US07414140B2
公开(公告)日:2008-08-19
申请号:US10872089
申请日:2004-06-18
IPC分类号: C07D209/12
CPC分类号: C07D209/12 , C07D209/24
摘要: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
摘要翻译: 提供氟伐他汀钠的多晶型物质及其制备方法。
-
公开(公告)号:US20060100446A1
公开(公告)日:2006-05-11
申请号:US11257828
申请日:2005-10-24
申请人: Judith Aronhime , Ramy Lidor-Hadas , Valerie Niddam-Hildesheim , Revital Lifshitz-Liron , Shlomit Wizel
发明人: Judith Aronhime , Ramy Lidor-Hadas , Valerie Niddam-Hildesheim , Revital Lifshitz-Liron , Shlomit Wizel
IPC分类号: C07D207/24
CPC分类号: C07D207/34 , A61K9/282 , A61K9/5021 , C07D405/06
摘要: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
-
公开(公告)号:US20060100267A1
公开(公告)日:2006-05-11
申请号:US11257886
申请日:2005-10-24
申请人: Judith Aronhime , Ramy Lidor-Hadas , Valerie Niddam-Hildesheim , Revital Lifshitz-Liron , Shlomit Wizel
发明人: Judith Aronhime , Ramy Lidor-Hadas , Valerie Niddam-Hildesheim , Revital Lifshitz-Liron , Shlomit Wizel
IPC分类号: A61K31/401 , C07D207/24
CPC分类号: C07D207/34 , A61K9/282 , A61K9/5021 , C07D405/06
摘要: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
-
-
-
-
-
-
-
-
-